id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0363-0059,FDA,FDA-2007-N-0363,"Electronic Distribution of Prescribing Information for Human Prescription
Drugs, Including Biological Products; Extension of Comment Period",Proposed Rule,Extension of Comment Period,2015-03-09T04:00:00Z,2015,3,2015-03-09T04:00:00Z,2015-05-19T03:59:59Z,2015-06-02T01:30:45Z,2015-05336,0,0,0900006481a342ea
FDA-2007-N-0363-0051,FDA,FDA-2007-N-0363,Request for Extension from Pharmaceutical Printed Literature Association (PPLA) and American Forest & Paper Association (AF&PA),Other,Request for Extension,2015-02-11T05:00:00Z,2015,2,2015-02-11T05:00:00Z,,2016-10-31T15:07:25Z,,0,0,09000064819efc0e
FDA-2007-N-0363-0046,FDA,FDA-2007-N-0363,Reference 6 Electronic Distribution of Labeling Proposed Rule Final Report,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:25:50Z,,0,0,0900006481983f98
FDA-2007-N-0363-0044,FDA,FDA-2007-N-0363,Reference 4 Internal Analysis of Safety-Related Labeling Changes Approved by FDA Between 2003 and 2013 Source MedWatch Drug Safety Labeling Changes,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:22:40Z,,0,0,0900006481983be8
FDA-2007-N-0363-0047,FDA,FDA-2007-N-0363,Reference 7 Electronic Distribution of Prescribing Information for Human Prescriptions Drugs Including Biological Products,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:27:12Z,,0,0,0900006481983f99
FDA-2007-N-0363-0042,FDA,FDA-2007-N-0363,Reference 2 Electronic Drug Lageling No Consensus on the Advantages and Disadvantages of Its Exclusive Use,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:17:51Z,,0,0,0900006481983be4
FDA-2007-N-0363-0041,FDA,FDA-2007-N-0363,Reference 1 Final Report Analysis of the Feasibility of Safety Labeling Changes Implementation Timeline,Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:15:54Z,,0,0,0900006481983be5
FDA-2007-N-0363-0040,FDA,FDA-2007-N-0363,Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products,Proposed Rule,Amendment,2014-12-18T05:00:00Z,2014,12,2014-12-18T05:00:00Z,2015-03-19T03:59:59Z,2015-03-19T02:14:33Z,2014-29522,0,0,0900006481982461
FDA-2007-N-0363-0045,FDA,FDA-2007-N-0363,"Reference 5 Incidence of New Postmarket Boxed Warnings for New
Molecular Entities",Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:24:00Z,,0,0,0900006481983f97
FDA-2007-N-0363-0043,FDA,FDA-2007-N-0363,"Reference 3 Ho et al An assessment of pharmacists readiness
for paperless labeling a national survey",Supporting & Related Material,Background Material,2014-12-18T05:00:00Z,2014,12,,,2014-12-18T20:21:00Z,,0,0,0900006481983be7
FDA-2007-N-0363-0039,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:20:02Z,,0,1,090000648197c5c5
FDA-2007-N-0363-0035,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:14:17Z,,0,1,090000648197c0fb
FDA-2007-N-0363-0037,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:16:51Z,,0,1,090000648197c5c3
FDA-2007-N-0363-0038,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:18:20Z,,0,1,090000648197c5c4
FDA-2007-N-0363-0034,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:13:28Z,,0,1,090000648197c0fa
FDA-2007-N-0363-0036,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:16:01Z,,0,1,090000648197c5c1
FDA-2007-N-0363-0033,FDA,FDA-2007-N-0363,Withdrawn,Supporting & Related Material,,2014-12-16T00:00:00Z,2014,12,,,2014-12-16T18:11:53Z,,0,1,090000648197c0f9
FDA-2007-N-0363-0015,FDA,FDA-2007-N-0363,FDA,Notice,N-Notice,2007-10-24T04:00:00Z,2007,10,2007-10-19T04:00:00Z,2007-12-07T04:59:59Z,2008-04-04T00:36:28Z,,0,0,090000648042bacf
FDA-2007-N-0363-0014,FDA,FDA-2007-N-0363,"Transcript of April 27, 2007 Hearing",Other,TR-Transcript,2007-06-11T04:00:00Z,2007,6,,,2008-04-04T00:36:27Z,,0,0,090000648042bab5
FDA-2007-N-0363-0012,FDA,FDA-2007-N-0363,"Agenda for April 27, 2007 Public Hearing",Other,LST-List,2007-04-23T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba9c
FDA-2007-N-0363-0013,FDA,FDA-2007-N-0363,"Agenda for April 27, 2007 Public Hearing",Other,LST-List,2007-04-23T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba9d
FDA-2007-N-0363-0011,FDA,FDA-2007-N-0363,"Rickman, William",Other,EAPE-Electronic Request for Appearance,2007-04-20T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba99
FDA-2007-N-0363-0010,FDA,FDA-2007-N-0363,"Fahey, Mike",Other,EAPE-Electronic Request for Appearance,2007-04-19T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba94
FDA-2007-N-0363-0009,FDA,FDA-2007-N-0363,"Pallas, LuAnn",Other,EAPE-Electronic Request for Appearance,2007-04-16T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba87
FDA-2007-N-0363-0008,FDA,FDA-2007-N-0363,"Chan, Carmen",Other,EAPE-Electronic Request for Appearance,2007-04-16T04:00:00Z,2007,4,,,2008-04-04T00:36:28Z,,0,0,090000648042ba85
FDA-2007-N-0363-0007,FDA,FDA-2007-N-0363,"McKeever, Paula",Other,EAPE-Electronic Request for Appearance,2007-04-13T04:00:00Z,2007,4,,,2008-04-04T00:36:28Z,,0,0,090000648042ba7f
FDA-2007-N-0363-0006,FDA,FDA-2007-N-0363,"Spearmon, Jo Ann",Other,EAPE-Electronic Request for Appearance,2007-04-12T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba78
FDA-2007-N-0363-0004,FDA,FDA-2007-N-0363,"Norden, Janet",Other,EAPE-Electronic Request for Appearance,2007-04-10T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba6d
FDA-2007-N-0363-0005,FDA,FDA-2007-N-0363,"Lee, Koung",Other,EAPE-Electronic Request for Appearance,2007-04-10T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba70
FDA-2007-N-0363-0002,FDA,FDA-2007-N-0363,"Garber, Mat",Other,EAPE-Electronic Request for Appearance,2007-04-03T04:00:00Z,2007,4,,,2008-08-19T14:18:00Z,,0,0,090000648042ba49
FDA-2007-N-0363-0003,FDA,FDA-2007-N-0363,"Menchaca, Ramon",Other,EAPE-Electronic Request for Appearance,2007-04-03T04:00:00Z,2007,4,,,2008-04-04T00:36:27Z,,0,0,090000648042ba4a
FDA-2007-N-0363-0001,FDA,FDA-2007-N-0363,"Electronic Distribution of Prescribing Information for Prescription Drug
Products; Public Hearing; Request for Comments",Notice,NHC-Notice of Hearing Before Commissioner,2007-03-28T04:00:00Z,2007,3,2007-03-28T04:00:00Z,2007-06-23T03:59:59Z,2014-11-07T19:16:37Z,07–1604,0,0,090000648042ba47